Claire Bennett, MA
Master of Arts, Medical Communication
Master of Arts, Medical Communication
Claire Bennett is a Senior Health & Medical Writer specializing in metabolic therapeutics, GLP-1 receptor agonist pharmacotherapy, and evidence-based weight management. She holds a Master of Arts in Medical Communication from Johns Hopkins University, where her capstone research examined how direct-to-patient pharmaceutical content influences treatment adherence in chronic disease populations. Before joining the Losing Weight RX editorial team, Claire spent four years as a health and science journalist covering the FDA beat for a Washington, D.C.-based digital health publication, where she reported on the regulatory trajectory of semaglutide from its Type 2 diabetes indication through its landmark obesity approval.
Claire transitioned into dedicated medical writing in 2021, drawn by the opportunity to produce the kind of deeply sourced, clinically rigorous content she felt was missing from the consumer weight-loss space. She has since authored over 80 long-form articles on GLP-1 medications, compounded peptide therapies, and the evolving telehealth weight-loss landscape. Her work is distinguished by its insistence on primary-source citation — she pulls directly from published clinical trials, FDA guidance documents, and peer-reviewed endocrinology journals rather than relying on secondary reporting.
As the founding and most senior writer at Losing Weight RX, Claire sets the editorial standard for every piece the team publishes. She is personally responsible for developing the site's clinical content framework, structured data methodology, and medical accuracy review process. When she isn't writing, she is monitoring the ClinicalTrials.gov pipeline for emerging obesity pharmacotherapy data and attending virtual sessions at the American Association of Clinical Endocrinology annual meeting.
